Date clarification: The scheduled 2026Q2 earnings call is today, Wednesday, July 29, 2026—not tomorrow. This preview is based on the company’s latest disclosed outlook and operating commentary ahead of the report.
Bunge enters 2Q with a materially improved fundamental backdrop versus the start of the year. In 1Q, it delivered $1.83 adjusted EPS, raised full-year adjusted EPS guidance to $9.00–$9.50 from $7.50–$8.00, and attributed the improvement principally to soybean and softseed processing/refining, supported by biofuel-related demand, stronger oilseed origination, and the enlarged Viterra platform.
The central question for this report is therefore not simply whether Bunge beats on 2Q EPS. Investors will be assessing whether:
Management’s prior commentary suggests an implied 2Q adjusted-EPS range of roughly $1.77–$1.97, centered near $1.87, based on its indication that approximately 40% of 2026 earnings should arrive in the first half. This is an analytical cadence implication, not company guidance.
The most important read-through will be the durability of elevated crush and oilseed-value-chain economics.
In 1Q, adjusted segment EBIT was:
| Segment | 1Q26 Adjusted EBIT | 1Q25 Adjusted EBIT |
|---|---|---|
| Soybean Processing & Refining | $377m | $241m |
| Softseed Processing & Refining | $195m | $82m |
| Tropical Oils & Specialty Ingredients | $45m | $23m |
| Grain Merchandising & Milling | $44m | $60m |
Soybean and softseed performance benefited from stronger operations in Argentina, Brazil, and North America; expanded Viterra-related capacity and origination; and better oil merchandising. For 2Q, investors should focus on:
A strong result in these two segments, accompanied by a confident discussion of 2H coverage, would be the cleanest positive catalyst.
The outlook is likely the stock’s most important earnings-day variable.
Bunge raised guidance after 1Q because the soybean and softseed businesses were improving faster than management had expected. But it also cautioned that the environment remained volatile and that the upgrade was weighted toward the first half. Key watch items:
The range also embeds notable moving parts outside operating execution: Bunge forecast a 22%–26% adjusted tax rate, $620m–$660m of net interest expense, and $1.5bn–$1.7bn of capital expenditures for 2026. Higher short-term debt and working-capital needs were already expected to raise interest expense beginning in 2Q.
Grain Merchandising & Milling was the relative weak point in 1Q. Adjusted EBIT declined to $44m from $60m, principally because high bunker-fuel costs hurt ocean freight. Management said global grain merchandising itself was roughly in line year over year, while wheat milling, cotton, and commercial services were positive.
This segment is inherently difficult to forecast, and investors should not expect smooth quarterly earnings. Still, 2Q commentary should address:
The Viterra transaction substantially deepened Bunge’s storage, origination, and logistics network. That should improve earnings resilience through different carry and trading environments—but the timing of the benefit may be uneven.
Management reduced its outlook for Tropical Oils & Specialty Ingredients following 1Q, citing weaker food-customer volumes, lower cocoa-butter-equivalent economics, uncertainty around tariffs and geopolitics, and customers remaining relatively short bought.
For 2Q, the issue is less the absolute dollar contribution and more whether this business is stabilizing. A further deterioration could offset part of the oilseed-processing strength. Investors should listen for updates on:
Longer term, Bunge views soy protein concentrates, specialty oils/fats, and the IFF soy-protein acquisition as strategic growth opportunities. They are unlikely to determine 2Q, but their ramp and commercial traction matter for the company’s medium-term earnings bridge.
Viterra integration is increasingly central to the BG thesis. At its March Investor Day, Bunge increased its view of achievable Viterra cost synergies to approximately $350m annually, versus the original $250m target, and identified $250m–$300m of targeted commercial opportunities. Management has also emphasized additional, harder-to-quantify benefits from network optimization, internalizing flows, freight integration, direct origination, and using a broader asset base to capture regional dislocations.
For this quarter, investors should look for:
The bullish case is that Bunge is entering an earnings-accretion phase: a more favorable processing environment combines with higher Viterra synergies, maturing capital projects, and a larger global network. The risk is that investors are already anticipating that outcome, leaving little room for execution slippage.
Bunge’s working-capital-intensive model makes cash flow and leverage as important as headline earnings.
At the end of 1Q, the company had:
Management views RMI as economically important and generally financeable, but investors should still monitor changes in inventory, margin deposits, short-term debt, and operating cash flow—especially in a period of elevated commodity prices and geopolitical/logistics disruption.
Capital allocation is also becoming more shareholder-oriented. Bunge aims over the cycle to return roughly 50% of discretionary cash flow through dividends and repurchases, while completing the remaining $250m of Viterra-related buybacks during 2026. Any indication that cash generation is exceeding planned investment needs could support expectations for additional repurchases, though management has also highlighted a desire to maintain credit-metric flexibility.
BG closed at $117.40 on July 28, recovering roughly 11.9% from its July 1 close, but remaining about 9.7% below its June 1 close. That pattern suggests the shares have already recovered some optimism around the oilseed/biofuel and integration narrative, while still reflecting uncertainty around the durability of earnings, freight and geopolitical costs, and the second-half margin outlook.
Bunge’s 2Q report is best viewed as a test of whether 1Q represented the beginning of a more durable earnings step-up. The most investable signals would be: continued strength in soy and softseed value chains, preservation of the $9.00–$9.50 outlook, credible evidence of faster Viterra synergy realization, and stable leverage despite seasonal working-capital demands.
Conversely, investors should be alert to any indication that the 1Q upgrade was mainly a short-lived first-half benefit, particularly if management becomes more cautious on oilseed curves, freight, tropical oils, or second-half customer commitments.